Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no longer rational to reject prostate cancer screening on one hand while ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

Prostate cancer is the most common cancer in men in the United Kingdom, with roughly 55,300 new cases diagnosed every year (2017-2019). According to Cancer Research UK, prostate cancer is the second ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

If you think plastic pollution is something that floats out at sea or washes up on a beautiful Bahamian beach, think again.

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.